PMA device
Organ Care System (OCS) Liver
TransMedics, Inc. · Normothermic Machine Perfusion System For The Preservation Of Donor Livers Prior To Transplantation (QQK, Class III) · First FDA decision Sep 28, 2021, newest Mar 9, 2026Liver disease and liver cancer
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
5
PMA pathway
Device trials
112
Naming "Organ Care"
MAUDE reports
4
Brand "Organ Care", since 2015
PubMed studies
152
Mentioning "Organ Care"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Organ Care System (OCS) Liver
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 5 of 5 decisions filed under this name.
- Organ Care System (OCS) LiverPMA supplement
P200031-S014 · Decided Mar 9, 2026 · 76 days after receipt · Normal 180 Day Track No User Fee
Device type: Normothermic machine perfusion system for the preservation of donor livers prior to transplantation (QQK) · GI, Urology & Nephrology
- Organ Care System (OCS) LiverPMA supplement
P200031-S007 · Decided Jan 13, 2025 · 179 days after receipt · Normal 180 Day Track
Device type: Normothermic machine perfusion system for the preservation of donor livers prior to transplantation (QQK) · GI, Urology & Nephrology
- Organ Care System (OCS®) LiverPMA supplement
P200031-S006 · Decided Feb 23, 2024 · 177 days after receipt · Normal 180 Day Track No User Fee
Device type: Normothermic machine perfusion system for the preservation of donor livers prior to transplantation (QQK) · GI, Urology & Nephrology
2 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Liver Transplantation for MalignanciesNational analysisReview closedCAG-00091RUpdated Sep 18, 2026
- Liver Transplantation for Malignancies other than Hepatocellular CarcinomaNational analysisReview closedCAG-00101NUpdated Sep 15, 2026
- Liver Transplantation for MalignanciesNational analysisReview closedCAG-00091NUpdated Sep 15, 2026
- Liver TransplantationNational analysisReview closedCAG-00053NUpdated Sep 15, 2026
- Adult Liver TransplantationNational determinationOn the books260.1Updated Aug 17, 2026
- Dental Examination Prior to Kidney TransplantationNational determinationOn the books260.6Updated Jun 15, 2020
- Nonselective (Random) Transfusions and Living Related Donor Specific Transfusions (DST) in Kidney TransplantationNational determinationOn the books110.16Updated Jun 12, 2020
- Pediatric Liver TransplantationNational determinationOn the books260.2Updated Apr 20, 2020
Clinical trials
Device studies on ClinicalTrials.gov that name "Organ Care", any status and sponsor, newest update first.
- Peds Proton TherapyRecruiting
University of Wisconsin, MadisonAcademic, hospital or other
NCT07949773 · 80 participants (planned) · Start Oct 13, 2026 · Primary completion Jan 2029
Device: RayTracker and RayAdaptive Software Analysis · For: Radiation
Sites: Madison, Wisconsin
- Hypothermic Kidney Machine Perfusion With OmnisolNot yet recruiting
Vivalyx GmbHNot on our public-company list
NCT07920926 · 16 participants (planned) · Start Jan 2027 · Primary completion May 2027
Device: Omnisol organ preservation solution · For: End Stage Renal Disease (ESRD); Kidney Transplant; Kidney Failure and 1 more
- Prehospital mSOFA-Kit Decision Support for the Detection of Multiple Organ FailurePivotal-lookingNot yet recruiting
University of ValladolidAcademic, hospital or other
NCT07928674 · 3,780 participants (planned) · Start Apr 1, 2027 · Primary completion Oct 31, 2029
Device: mSOFA-Kit · For: Multiple Organ Failure; Critical Illness
Sites: Valladolid, Spain
109 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Organ Care", and for the whole product code for context.
This brand
4 reports: 2 malfunction, 0 injury, 0 death
Whole product code QQK
566 reports: 426 malfunction, 135 injury, 3 death
Newest reports for this brand
MW6003839 · Received Oct 13, 2026 · Event dated Sep 17, 2026
Device type: Organ Care System (Ocs) Heart System (QIK)
Device problem as coded: Obstruction of Flow; Pumping Problem
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
MW6001546 · Received Aug 26, 2026 · Event dated Aug 11, 2026
Device type: Organ Care System (Ocs) Heart System (QIK)
Device problem as coded: Pumping Stopped
Patient problem as coded: Insufficient Information
- TRANSMEDICS ORGAN CARE SYSTEM (OCS) LIVERMalfunction
MW5175102 · Received Aug 21, 2025 · Event dated Aug 8, 2025
Device type: Organ Care System (Ocs) Heart System (QIK)
Device problem as coded: Defective Device; Infusion or Flow Problem
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
1 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Organ Care"[tiab]. The summary above synthesizes these.
- EVLP: Ready for Prime Time?
Loor G · Semin Thorac Cardiovasc Surg · 2019Review
- Organ Care System Heartࡊ in donors requiring high-risk excision of suspected neoplastic lesions.
Olivieri GM, Carrozzini M, Lanfranconi M, et al. · Int J Artif Organs · 2022
- Donors after circulatory death heart trial.
Shudo Y, Benjamin-Addy R, Koyano TK, et al. · Future Cardiol · 2021Research Support, Non-U.S. Gov't
- Playing the Transplant Lottery: Did the Odds of Winning Just Improve?
Rao S, Rogers JG · JACC Heart Fail · 2024Editorial, Comment
- Beating Heart Transplants-Overview and Implications for Anesthesiologists.
Kothari P, Kiwakyou LM, Guenthart BA, et al. · J Cardiothorac Vasc Anesth · 2024
- The TransMedics Organ Care System for the liver receives FDA pre-market approval.
Chang DD, Han JJ · Artif Organs · 2022News
- Donor Heart Recovery and Preservation Modalities in 2024.
Lerman JB, Agarwal R, Patel CB, et al. · JACC Heart Fail · 2024Review, Research Support, N.I.H., Extramural
- Ex-Vivo Preservation with the Organ Care System in High Risk Heart Transplantation.
Rojas SV, Avsar M, Ius F, et al. · Life (Basel) · 2022
- Organ Care System Lung resulted in lower apoptosis and iNOS expression in donor lungs.
Calabrese F, Schiavon M, Perissinotto E, et al. · Am J Transplant · 2020Observational Study, Research Support, Non-U.S. Gov't
- Surgical techniques for cardiac allograft procurement and perfusion in controlled donation after circulatory death.
Loforte A, Marro M, Simonato E, et al. · Ann Cardiothorac Surg · 2024Editorial
- Ex-Vivo Preservation of Heart Allografts-An Overview of the Current State.
Kothari P · J Cardiovasc Dev Dis · 2023
- Impact of Portable Normothermic Blood-Based Machine Perfusion on Outcomes of Liver Transplant: The OCS Liver PROTECT Randomized Clinical Trial.
Markmann JF, Abouljoud MS, Ghobrial RM, et al. · JAMA Surg · 2022Multicenter Study, Randomized Controlled Trial
Other devices of this type
Also filed under product code QQK.
- OrganOx metra® SystemOrganox Limited · PMA 2026
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.